HaemaLogiX Pty. Ltd logo

HaemaLogiX Pty. Ltd

HaemaLogiX is a biotech company focused on the development of novel immuno-oncology and immunotherapies for the treatment of haematologic malignancies and auto-immune diseases, including monoclonal antibodies and CAR T-cell technologies.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.haemalogix.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Cicada InnovationsSuite 145, 4 Cornwallis Street Eveleigh NSW 2015
Eveleigh
Australia
Email
Contact Number
+61 2 9209 4444

HaemaLogiX is a biotech company focused on the development of novel immuno-oncology and immunotherapies for the treatment of haematologic malignancies and auto-immune diseases, including monoclonal antibodies and CAR T-cell technologies.[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”” connections=”true” suffix=””]

In July 2017 HaemaLogiX acquired commercialisation rights from Westmead Institute for Medical Research and its allied institutes for commercialisation rights to an immuno-oncology agent designed to target bone marrow malignant cancer cells of multiple myeloma patients. HaemaLogiX together with the Westmead research team are preparing to test the novel CAR T-cell therapy in myeloma patients commencing in late 2018. Financial terms remains undisclosed.

In Mar 2015, HaemaLogiX acquired assest of Immune System Therapeutics (IST) including drug called MDX-1097 or IST-1097, (now named KappaMab), that is being developed for initial use in the treatment of a fatal form of cancer. IST had co-development/commercialisation agreements with University of Technology, Sydney, Medarex Inc/BMS Inc. and Celgene Inc based on two of ISTs targets and monoclonal antibodies. IST successfully completed phase I and phase IIa clinical trials with its primary antibody therapy for multiple myeloma.

In Mar 2015, HaemaLogiX raised nearly $AUS 2 Mn through Series A financing medical Research, and Alexandria Real Estate.